Based on our Pharmacor advisory service entitled Osteoporosis, Decision Resources is offering an exclusive analyst call entitled Prolia is Approved for the Treatment of Postmenopausal Osteoporosis: How Will It Compete in This Mature, Crowded Market? Because this presentation features major updates, it is ONLY available to purchasers of this Pharmacor advisory service..

This analyst call was held on June 17, 2010. Contact us to learn how you can purchase this Pharmacor advisory service and access a recorded playback of this event.

Click here to view the invite.